Ascendis Pharma A/S SEC filings ASND
Ascendis Pharma A/S has 795 filings in SEC EDGAR's recent list, going back to Aug 1, 2014. Its latest annual report, Form 20-F, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 424B5 | Prospectus supplement | Sep 18, 2024 | — |
| F-3ASR | Filing | Sep 18, 2024 | — |
| S-8 | Employee stock plan registration | Sep 4, 2024 | — |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Dec 9, 2021 | — |
| 424B5 | Prospectus supplement | Sep 2, 2021 | — |
| 424B5 | Prospectus supplement | Aug 31, 2021 | — |
| F-3ASR | Filing | May 27, 2021 | — |
| S-8 | Employee stock plan registration | Mar 10, 2021 | — |
| 424B5 | Prospectus supplement | Jul 9, 2020 | — |
| 424B5 | Prospectus supplement | Jul 6, 2020 | — |
| 424B5 | Prospectus supplement | Mar 6, 2019 | — |
| 424B5 | Prospectus supplement | Mar 4, 2019 | — |
| 424B5 | Prospectus supplement | Feb 8, 2019 | — |
| S-8 | Employee stock plan registration | Nov 28, 2018 | — |
| F-3ASR | Filing | May 30, 2018 | — |
| 424B5 | Prospectus supplement | Feb 23, 2018 | — |
| F-3MEF | Filing | Feb 21, 2018 | — |
| 424B5 | Prospectus supplement | Feb 20, 2018 | — |
| 424B5 | Prospectus supplement | Sep 28, 2017 | — |
| 424B5 | Prospectus supplement | Sep 26, 2017 | — |
| 424B5 | Prospectus supplement | May 23, 2017 | — |
| S-8 | Employee stock plan registration | Mar 22, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 22, 2017 | — |
| S-8 | Employee stock plan registration | Nov 30, 2016 | — |
| 424B5 | Prospectus supplement | Oct 19, 2016 | — |
| 424B5 | Prospectus supplement | Oct 18, 2016 | — |
| S-8 | Employee stock plan registration | Aug 31, 2016 | — |
| S-8 | Employee stock plan registration | May 20, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | May 20, 2016 | — |
| S-8 | Employee stock plan registration | Apr 18, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 2, 2016 | — |
| S-8 | Employee stock plan registration | Mar 26, 2015 | — |
| 424B4 | Prospectus | Jan 28, 2015 | — |
| F-1MEF | Filing | Jan 27, 2015 | — |
| F-6 | Form f-6 | Jan 26, 2015 | — |
| FWP | Free writing prospectus | Jan 26, 2015 | — |
| F-1/A | Amendment no. 2 to form f-1 | Jan 26, 2015 | — |
| F-1/A | Amendment no. 1 to registration statement on form f-1 | Jan 16, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Dec 18, 2014 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ASND (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Denmark
- Headquarters
- Hellerup
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1612042
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.